Literature DB >> 29404622

[Pathogenesis of atopic dermatitis].

C Scheerer1, K Eyerich2.   

Abstract

Atopic dermatitis (AD) is one of the most common chronic inflammatory diseases and is also one of the most frequent reasons to consult a dermatologist. Over the past few years there has been a rapidly growing understanding of the cellular, molecular and immunological relationships as well as genetic variations, which leads to a better comprehension of the disease. Consequently, there are innovative targeted therapies in clinical studies or already approved for therapy. To make reasonable use of the new targeted therapies a good understanding of the pathogenesis is very important. In the future, stratification of patients with AD and the resulting personalized therapies will gain in importance. This review depicts the up to date state of knowledge on the complex pathogenesis of AD.

Entities:  

Keywords:  Filaggrin; Immunology; Interleukin; Pruritus; T-Lymphocytes, helper-inducer

Mesh:

Substances:

Year:  2018        PMID: 29404622     DOI: 10.1007/s00105-018-4127-4

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  33 in total

1.  Changes in the ceramide profile of atopic dermatitis patients.

Authors:  Junko Ishikawa; Hirofumi Narita; Naoki Kondo; Mitsuyuki Hotta; Yutaka Takagi; Yoshinori Masukawa; Takashi Kitahara; Yoshinori Takema; Satomi Koyano; Soji Yamazaki; Atsushi Hatamochi
Journal:  J Invest Dermatol       Date:  2010-06-24       Impact factor: 8.551

Review 2.  The role of the histamine H4 receptor in atopic dermatitis.

Authors:  Susanne Mommert; Maria Gschwandtner; Ralf Gutzmer; Thomas Werfel
Journal:  Curr Allergy Asthma Rep       Date:  2011-02       Impact factor: 4.806

3.  Der p1 and Der p2-Specific T Cells Display a Th2, Th17, and Th2/Th17 Phenotype in Atopic Dermatitis.

Authors:  Lennart M Roesner; Annice Heratizadeh; Gabriele Begemann; Petra Kienlin; Susanne Hradetzky; Margarete Niebuhr; Britta Eiz-Vesper; Christian Hennig; Gesine Hansen; Véronique Baron-Bodo; Philippe Moingeon; Thomas Werfel
Journal:  J Invest Dermatol       Date:  2015-04-28       Impact factor: 8.551

Review 4.  Immunology of atopic eczema: overcoming the Th1/Th2 paradigm.

Authors:  K Eyerich; N Novak
Journal:  Allergy       Date:  2013-07-29       Impact factor: 13.146

Review 5.  Contrasting pathogenesis of atopic dermatitis and psoriasis--part II: immune cell subsets and therapeutic concepts.

Authors:  Emma Guttman-Yassky; Kristine E Nograles; James G Krueger
Journal:  J Allergy Clin Immunol       Date:  2011-03-21       Impact factor: 10.793

Review 6.  Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus.

Authors:  Martin Steinhoff; John Bienenstock; Martin Schmelz; Marcus Maurer; Ed Wei; Tamás Bíró
Journal:  J Invest Dermatol       Date:  2006-08       Impact factor: 8.551

7.  Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema.

Authors:  J M Jungersted; H Scheer; M Mempel; H Baurecht; L Cifuentes; J K Høgh; L I Hellgren; G B E Jemec; T Agner; S Weidinger
Journal:  Allergy       Date:  2010-02-04       Impact factor: 13.146

8.  Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling.

Authors:  Stefanie Eyerich; Kilian Eyerich; Davide Pennino; Teresa Carbone; Francesca Nasorri; Sabatino Pallotta; Francesca Cianfarani; Teresa Odorisio; Claudia Traidl-Hoffmann; Heidrun Behrendt; Stephen R Durham; Carsten B Schmidt-Weber; Andrea Cavani
Journal:  J Clin Invest       Date:  2009-11-16       Impact factor: 14.808

Review 9.  Innate immunity in atopic dermatitis.

Authors:  Andreas Wollenberg; Helen-Caroline Räwer; Jürgen Schauber
Journal:  Clin Rev Allergy Immunol       Date:  2011-12       Impact factor: 10.817

10.  Shared genetic origin of asthma, hay fever and eczema elucidates allergic disease biology.

Authors:  Manuel A Ferreira; Judith M Vonk; Hansjörg Baurecht; Ingo Marenholz; Chao Tian; Joshua D Hoffman; Quinta Helmer; Annika Tillander; Vilhelmina Ullemar; Jenny van Dongen; Yi Lu; Franz Rüschendorf; Jorge Esparza-Gordillo; Chris W Medway; Edward Mountjoy; Kimberley Burrows; Oliver Hummel; Sarah Grosche; Ben M Brumpton; John S Witte; Jouke-Jan Hottenga; Gonneke Willemsen; Jie Zheng; Elke Rodríguez; Melanie Hotze; Andre Franke; Joana A Revez; Jonathan Beesley; Melanie C Matheson; Shyamali C Dharmage; Lisa M Bain; Lars G Fritsche; Maiken E Gabrielsen; Brunilda Balliu; Jonas B Nielsen; Wei Zhou; Kristian Hveem; Arnulf Langhammer; Oddgeir L Holmen; Mari Løset; Gonçalo R Abecasis; Cristen J Willer; Andreas Arnold; Georg Homuth; Carsten O Schmidt; Philip J Thompson; Nicholas G Martin; David L Duffy; Natalija Novak; Holger Schulz; Stefan Karrasch; Christian Gieger; Konstantin Strauch; Ronald B Melles; David A Hinds; Norbert Hübner; Stephan Weidinger; Patrik K E Magnusson; Rick Jansen; Eric Jorgenson; Young-Ae Lee; Dorret I Boomsma; Catarina Almqvist; Robert Karlsson; Gerard H Koppelman; Lavinia Paternoster
Journal:  Nat Genet       Date:  2017-10-30       Impact factor: 38.330

View more
  4 in total

Review 1.  [Personalized medicine in allergology].

Authors:  W Pfützner; J Pickert; C Möbs
Journal:  Hautarzt       Date:  2019-01       Impact factor: 0.751

2.  [Atopic eczema].

Authors:  A Wollenberg; T Biedermann
Journal:  Hautarzt       Date:  2018-03       Impact factor: 0.751

3.  Paeonol inhibits the development of 1‑chloro‑2,4‑dinitrobenzene‑induced atopic dermatitis via mast and T cells in BALB/c mice.

Authors:  Yujiao Meng; Zhengrong Liu; Chunyan Zhai; Tingting Di; Lu Zhang; Lei Zhang; Xinran Xie; Yan Lin; Ning Wang; Jingxia Zhao; Yan Wang; Ping Li
Journal:  Mol Med Rep       Date:  2019-02-25       Impact factor: 2.952

Review 4.  Context Dependent Role of Type 2 Innate Lymphoid Cells in Allergic Skin Inflammation.

Authors:  David A Rafei-Shamsabadi; Christoph S N Klose; Timotheus Y F Halim; Yakup Tanriver; Thilo Jakob
Journal:  Front Immunol       Date:  2019-11-06       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.